logo

Neubase Therapeutics, Inc. (NBSE)



Trade NBSE now with
  Date
  Headline
12/16/2020 6:38:32 AM NeuBase Announces Positive Preclinical In Vivo Data For PATrOL-enabled Anti-gene For Myotonic Dystrophy Type 1